TIAA CREF Investment Management’s Kindred Biosciences, Inc. KIN Stock Holding History

TIAA CREF Investment Management’s Portfolio KIN Stock Details KIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$521K	Sell	56,843 -12,600	-18%	-$128K	﹤0.01%	2584
2018 Q4	$760K	Buy	69,443 +5,525	+9%	+$69.6K	﹤0.01%	2391
2018 Q3	$892K	Buy	63,918 +10,799	+20%	+$146K	﹤0.01%	2474
2018 Q2	$566K	Sell	53,119 -8,308	-14%	-$81K	﹤0.01%	2735
2018 Q1	$531K	Hold	61,427	–	–	﹤0.01%	2710
2017 Q4	$580K	Buy	61,427 +2,859	+5%	+$22.3K	﹤0.01%	2710
2017 Q3	$460K	Sell	58,568 -5,068	-8%	-$38K	﹤0.01%	2863
2017 Q2	$547K	Buy	+63,636	New	+$457K	﹤0.01%	2825
2015 Q3	–	Sell	-10,969	Closed	-$75K	–	3169
2015 Q2	$75K	Sell	10,969 -25,202	-70%	-$179K	﹤0.01%	3179
2015 Q1	$258K	Sell	36,171 -18,530	-34%	-$128K	﹤0.01%	3031
2014 Q4	$408K	Sell	54,701 -2,170	-4%	-$18.4K	﹤0.01%	3010
2014 Q3	$526K	Hold	56,871	–	–	﹤0.01%	2955
2014 Q2	$1.06M	Buy	56,871 +28,094	+98%	+$477K	﹤0.01%	2693
2014 Q1	$533K	Buy	+28,777	New	+$549K	﹤0.01%	2920

Other funds holding KIN

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

TIAA CREF Investment Management's KIN Position: Q1 2019 in Review

TIAA CREF Investment Management reduced its Kindred Biosciences, Inc. (KIN) stake by 18% in Q1 2019, selling an estimated $128K and leaving 56,843 shares worth $521K. The position accounts for ﹤0.01% of the portfolio, ranked #2584.

TIAA CREF Investment Management first reported a position in KIN in Q1 2014 and has held it in 14 quarters since. The position peaked at $1.06M in Q2 2014. 75 funds tracked by Wall St. Rank hold KIN as of Q1 2019.

TIAA CREF Investment Management held 56,843 shares of Kindred Biosciences, Inc. worth $521K as of Q1 2019.
TIAA CREF Investment Management sold 12,600 Kindred Biosciences, Inc. shares in Q1 2019, an estimated $128K.
Kindred Biosciences, Inc. made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #2584 holding.
TIAA CREF Investment Management first reported a position in Kindred Biosciences, Inc. in Q1 2014 and has held it in 14 quarters since.
TIAA CREF Investment Management's Kindred Biosciences, Inc. position peaked at $1.06M in Q2 2014.
75 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.